Segment Information (Tables)

6 Months Ended

Jun. 30, 2019

Segment Information

Summary of results of operations by segment

	Dermatology		Contract		Corporate		Total
Three Months Ended June 30, 2019	Therapeutics		Research		and Other		Company
Revenue, net	$	4,979	$	3,807	$	(2,921)	$	5,865
Cost of revenue (excludes amortization)		1,709		3,819		(2,825)		2,703
Research and development		17,718		—		(96)		17,622
Sales and marketing		7,164		13		—		7,177
General and administrative		—		600		7,390		7,990
Goodwill impairment		18,504		—		—		18,504
Amortization of definite-lived intangible		1,660		—		—		1,660
Loss from operations	$	(41,776)	$	(625)	$	(7,390)	$	(49,791)
	Dermatology		Contract		Corporate		Total
Three Months Ended June 30, 2018	Therapeutics		Research		and Other		Company
Revenue, net	$	2,533	$	3,053	$	(1,910)	$	3,676
Cost of revenue		152		2,621		(1,592)		1,181
Research and development		13,984		—		—		13,984
Sales and marketing		12,360		8		—		12,368
General and administrative		—		521		7,600		8,121
Loss from operations	$	(23,963)	$	(97)	$	(7,918)	$	(31,978)
	Dermatology		Contract		Corporate		Total
Six Months Ended June 30, 2019	Therapeutics		Research		and Other		Company
Revenue, net	$	8,757	$	8,995	$	(6,846)	$	10,906
Cost of revenue (excludes amortization)		3,279		8,856		(6,655)		5,480
Research and development		37,732		—		(191)		37,541
Sales and marketing		16,976		32		—		17,008
General and administrative		—		1,113		15,067		16,180
Goodwill impairment		18,504		—		—		18,504
Amortization of definite-lived intangible		3,319		—		—		3,319
Loss from operations	$	(71,053)	$	(1,006)	$	(15,067)	$	(87,126)
	Dermatology		Contract		Corporate		Total
Six Months Ended June 30, 2018	Therapeutics		Research		and Other		Company
Revenue, net	$	2,533	$	5,554	$	(3,293)	$	4,794
Cost of revenue		152		4,740		(2,744)		2,148
Research and development		27,590		—		—		27,590
Sales and marketing		23,581		20		—		23,601
General and administrative		—		992		13,389		14,381
Loss from operations	$	(48,790)	$	(198)	$	(13,938)	$	(62,926)